← Leaderboards
Francois X Claret
University Of Texas Md Anderson Can Ctr
$2,656,647
Attributed
$2,656,647
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $324.4K · FY2005–11$500K$375K$250K$125K$0
'05
'06
'07
'08
'09
'10
'11
Funding mix
By agency
NIH$2,656,647 · 2
By mechanism
R01$2,508,409 · 1
R03$148,238 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Texas Md Anderson Can Ctr
Same institution · by research overlap
- Marsha L. Frazier$7,186,828
- Susan M Fischer$12,916,650
- Michael Oreilly$1,035,331
- David W Goodrich$12,830,398
- Miles Frome Wilkinson$18,695,635
Others in their field
Top investigators on “Cell Proliferation”
- John M Lachin · George Washington University$118,921,924
- David M Nathan · Massachusetts Institute Of Technology$118,921,924
- David Heimbrook · Leidos Biomedical Research, Inc.$103,164,048
- Timothy J Eberlein · Washington University$49,931,668
- Deirdre R. Meldrum · University Of Washington$37,202,510
- Robert A Weinberg · Whitehead Institute For Biomedical Res$32,735,166
Research focus
Cell ProliferationTranscription FactorCell CycleCyclin ECyclin-Dependent Kinase Inhibitor 1bCyclin-Dependent Kinase InhibitorComplexBinding (Molecular Function)ApoptosisBinding SitesAnchorage-Independent GrowthCcaat-Enhancer-Binding ProteinsBreast Cancer CellCell Cycle ProgressionCell Cycle ArrestBreast Cancer ModelBreast Cancer TreatmentCell Cycle RegulationBreast CarcinomaCell NucleusC-Jun Proto-OncogeneCellsBaseCyclin D1
Grant awards (12)
Targeting JAB1 Oncogenic Function in Breast Cancer$247,358
R01 · FY2011 · CA · contact PI
Targeting JAB1 Oncogenic Function in Breast Cancer$255,009
R01 · FY2010 · CA · contact PI
Targeting JAB1 Oncogenic Function in Breast Cancer$255,009
R01 · FY2009 · CA · contact PI
Targeting JAB1 Oncogenic Function in Breast Cancer$255,009
R01 · FY2008 · CA · contact PI
Targeting JAB1 Oncogenic Function in Breast Cancer$255,009
R01 · FY2007 · CA · contact PI
Molecular Mode of Action of JAB-1 in Cell Proliferation$243,515
R01 · FY2006 · CA · contact PI
Validation of new biomarker for human cancers$73,238
R03 · FY2006 · CA · contact PI
Molecular Mode of Action of JAB-1 in Cell Proliferation$249,375
R01 · FY2005 · CA
Validation of new biomarker for human cancers$75,000
R03 · FY2005 · CA
Molecular Mode of Action of JAB-1 in Cell Proliferation$249,375
R01 · FY2004 · CA
Molecular Mode of Action of JAB-1 in Cell Proliferation$249,375
R01 · FY2003 · CA
Molecular Mode of Action of JAB-1 in Cell Proliferation$249,375
R01 · FY2002 · CA